These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design. Musyoka TM; Njuguna JN; Tastan Bishop Ö Malar J; 2019 May; 18(1):159. PubMed ID: 31053072 [TBL] [Abstract][Full Text] [Related]
3. The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum. Sundararaj S; Singh D; Saxena AK; Vashisht K; Sijwali PS; Dixit R; Pandey KC PLoS One; 2012; 7(10):e47227. PubMed ID: 23077573 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4. Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140 [TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Sijwali PS; Shenai BR; Gut J; Singh A; Rosenthal PJ Biochem J; 2001 Dec; 360(Pt 2):481-9. PubMed ID: 11716777 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum. Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921 [TBL] [Abstract][Full Text] [Related]
15. The impact of whole genome sequence data on drug discovery--a malaria case study. Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369 [TBL] [Abstract][Full Text] [Related]
19. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery. Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005 [TBL] [Abstract][Full Text] [Related]
20. In silico identification of noncompetitive inhibitors targeting an uncharacterized allosteric site of falcipain-2. Hernández González JE; Salas-Sarduy E; Hernández Alvarez L; Barreto Gomes DE; Pascutti PG; Oostenbrink C; Leite VBP J Comput Aided Mol Des; 2021 Oct; 35(10):1067-1079. PubMed ID: 34617191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]